Higher intraocular pressure is linked with higher glaucoma risk in human cohorts, while a population-based study links older age with lower pressure. A human trial reports increased pressure with glucosamine over three months; another reports a decrease with omega-3 supplementation in normotensive adults.
80 findings in 63 papers from 1995 to 2026, 10 of them since June 2026
“Changes in intraocular pressure were significantly negatively associated with changes in optic nerve head vessel density”
Nicotinamide protects against intraocular pressure in Lmx1b mutant mice.
“treatment with vitamin B3 (nicotinamide), which enhances mitochondrial function and metabolic resilience in other contexts, significantly protected Lmx1b mutant mice from IOP elevation.”
Age is linked with lower intraocular pressure in humans (population-based) (from 14.1 mm Hg (SD: 3.6) to 13.0 mm Hg (SD: 4.2)).
“Intraocular pressure (IOP) decreased with age in a population-based study in Nepal, from a mean of 14.1 mm Hg among those 60-64 years old to 13.0 mm Hg among those 80 years old or older.”
Age is linked with lower intraocular pressure in humans (B = -0.020/year, p = 0.0001).
“Multiple regression analyses revealed that age was significantly negatively correlated with IOP (non-standardised beta (B) = -0.020/year, p = 0.0001).”
Humansamong right eyes without glaucoma, suspected glaucoma or other disorders which could affect correct IOP measurements
TyG index is linked with intraocular pressure in humans (mediation of BMI effect on IOP) (43.4% of total effect indirect (via TyG: 0.0182, hypertension: 0.0079, sequential: 0.0014)).
“Mediation analysis indicated that 43.4% of the total effect was indirect, mainly via TyG (0.0182), hypertension (0.0079), and their sequential path (0.0014).”
Intraocular pressure is associated with diabetes mellitus in humans (Intraocular pressure ≥20 mm Hg; prior diabetes diagnosis; adjusted for age and sex) (ORMH 1.83 (95% CI 1.08–3.09)).
“An IOP ≥20 mm Hg increased the risk of having been diagnosed with diabetes (ORMH 1.83; 95% CI 1.08-3.09).”
HumansIntraocular pressure ≥20 mm Hg; prior diabetes diagnosis; adjusted for age and sexn = 733
Systolic blood pressure is associated with intraocular pressure in humans (Per 10 mmHg higher systolic blood pressure) (+0.23 mmHg IOP per 10 mmHg higher systolic blood pressure; 95% CI 0.19–0.27).
“associated with an IOP that was, on average, 0.23 mmHg (95% confidence interval [CI], 0.19-0.27) or 0.24 mmHg (95% CI, 0.16-0.32) higher, respectively.”
Metabolic dysfunction-associated steatotic liver disease is associated with intraocular pressure in humans (Fatty liver compared with no fatty liver) (MD: 0.81 mmHg; 95% CI: 0.51–1.10).
“demonstrated a significantly higher mean IOP in patients with fatty liver (MD: 0.81 mmHg; 95% CI: 0.51-1.10; p=0.007).”
ReviewFatty liver compared with no fatty livern = 23,625
Intraocular pressure is associated with optic nerve head vessel density in humans following elbow plank and reverse plank (Elbow plank: inside disc b = -1.153, p = 0.02; peripapillary b = -0.369, p = 0.009. Reverse plank: whole image b = -0.589, p = 0.031.).
“Changes in intraocular pressure were significantly negatively associated with changes in optic nerve head vessel density”
Human trialfollowing elbow plank and reverse plankoptic nerve headpost-rest periodn = 12
Australians of European ancestry in the score’s top 10% had 10.04 times the odds of glaucoma compared with the remaining participants.Australians of European ancestry in the score’s top 10% had 10.04 times the odds of glaucoma compared with the remaining participants.
Genetically predicted sphingomyelin, a blood fat, was linked to higher glaucoma odds—an odds ratio of 1.58 per standard deviation, a measure of variation.Genetically predicted sphingomyelin, a blood fat, was linked to higher glaucoma odds—an odds ratio of 1.58 per standard deviation, a measure of variation.